The human squamous cell carcinoma cell line SCC83-
Head and neck squamous cell carcinoma is a common tumor that accounts for 6% of all solid tumors in humans (1) . Although smoking and alcohol are often considered risk factors (2, 3) , the route by which the epithelial cell acquires its tumorigenic potential is not clear. At the molecular level, the activation of oncogenes and the inactivation of tumor suppressor genes are believed to play major roles in tumorigenicity (4) . The most commonly altered genes in squamous carcinoma are c-myc,pS3, and ras. Increased expression of the c-myc gene has been observed in squamous cell carcinomas (5) . Mutations in the p53 gene have been reported in 34% of mucosal head and neck squamous carcinomas (6) . Alterations of these genes have not been identified in all squamous carcinoma cells; for example, ras gene mutations are present in only 15% of human tumors (7) and are very rare in head and neck squamous cell carcinomas (8) . Despite an increasing number of newly discovered tumor susceptibility genes, the mutational events that result in squamous cell carcinomas are unknown.
The SCC-83-01-82 (SCC) cells are nontumorigenic in nude mice, yet they can be converted to a tumorigenic phenotype after treatment with the mutagen methyl methanesulfonate (MMS). This MMS-induced conversion is not associated with
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additional mutations in commonly investigated tumor susceptibility genes (9) (10) (11) .
To identify the gene(s) involved with the conversion of human nontumorigenic SCC cells to a tumorigenic stage, we developed a human tumor-related gene isolation system which combines the concept of transfection-mediated expression cloning and expression of the malignant stage in nude mice. This approach to the study of conversion of nontumorigenic SCC cells eliminated the necessity to use a nonhuman tumorigenic mammalian assay system to evaluate the tumorigenicity of these converted cells. The 3T3 mouse cell transformation assay (12, 13) and the provirus tagging (for a review see ref. 14) methods depend on the presence of specific DNA sequences for the introduced DNA. These specific sequences serve as "tags" to locate the relevant transforming genes. Specifically, one of the limitations of the method used in the 3T3 system is that the human Alu repeat is used as a tag against a mouse genomic DNA background; therefore it is not suitable for identification of any tumor susceptibility gene that does not transform the mouse cells. In the case of the proviral tagging method, a viral sequence tag provides a method for identifying a restricted number of cell types, namely those cells that will support virus replication. Another method uses mammalian cell expression cloning or transfection-mediated expression cloning (15) (16) (17) . These methods were developed to isolate genes according to their functional expression. These genes can then be identified either by cloning the vector sequence tag or by plasmid rescue (18) . However, because of the limitation of the selection method (18, 19) , this system, when used for oncogene isolation, has yielded only genes related to focus formation in mouse 3T3 cells. Here we report the establishment of a tumorigenic squamous carcinoma cell line (CATR1) that acquired tumorigenicity in nude mice after transfection of nontumorigenic SCC cells with a cDNA expression library. We propose that the gene designated CATR1.3 § may be involved in the tumorigenic conversion of SCC cells by the transfected expression cDNA library. The combination of transfectionmediated expression cloning and tumorigenic selection in nude mice can be used to identify unknown tumor susceptibility genes. atmosphere for 3-5 hr in medium supplemented with 10% FBS; growth medium was changed every 2 or 3 days as described (9) .
MATERIALS AND METHODS
cDNA Library Construction. Total RNA was isolated from the SCC83-01-82CA (CA) cells as described (20) . Poly(A)+ RNA was selected by using the FastTrack mRNA isolation method (Invitrogen). Five micrograms of poly(A)+ RNA was used to synthesize cDNA, using oligo(dT) primers and Superscript reverse transcriptase (GIBCO/BRL). The cDNA library was constructed by using the Librarian cDNA library construction kit (Invitrogen). Briefly, BstXI cloning linkers (5'-GAATTCCACCACA/5'-GTGGAATTC) were 250 ,ug/ml for the selection of pRC/RSV-transfected cells.
After 2 days, the cell cultures were split 1 to 4 in MEM with 10% FBS and G418 at 250 ,tg/ml, and after 2 weeks the G418-resistant colonies were pooled and the cells were grown to generate >107 cells.
Tumorigenicity Selection in nude mice. Transfected cells were harvested by trypsinization. The cells were washed and resuspended in MEM at -2 x 107 per ml. Three-to 4-week-old male gnotobiotic nude mice were splenectomized and then 107 cells were injected subcutaneously into their flanks as described (9) . For each batch of transfected cells, one to four sites on each mouse were injected. Tumors that were 1-2 cm in length were harvested for histological analysis and cell culture. Tumorigenic assays for the derivative cells were performed as previously described (9).
Southern Analysis. DNA isolation was carried out according to methods described by Sambrook et al. (21) . Electrophoresis was carried out on an 0.8% agarose gel in Tris acetate/EDTA buffer. Southern blot hybridization was performed as described (23) . Vector probes were prepared by using a United States Biochemical random primer labeling kit and linearized plasmid pRC/RSV according to the supplier.
Northern Analysis. Electrophoresis and Northern transfer were carried out by using methods described by Fourney et al. (24) . Briefly, 1 ,ug of poly(A)+ RNA was loaded per lane. The probes were labeled by random priming and probe at 1 x 106 cpm/ml was used in the hybridization protocol as described (25) .
Reverse Transcription PCR (RT-PCR). RT-PCR amplification was carried out on a standard thermal cycler according to the methods described in the GeneAmp RNA PCR kit (Perkin-Elmer/Cetus). The cloning linker specific primer was 5'-GCCAGTGTGGTGGAATTC. The amplification cycle used in this procedure was 95°C for 2 min, then 95°C for 1 min, 56°C for 1 min, and 72°C for 2 min, through 35 cycles.
Cloning and Sequencing of PCR Product. RT-PCR product was cloned by using the PCRScript cloning kit (Stratagene) according to the manufacturer. Several clones were selected for sequencing for the purpose of sequence verification. Double-stranded plasmid bearing CATRI.3 cDNA was sequenced by using USB Sequenase (United States Biochemical).
Homology Search. The DNA sequence and the derived protein sequence were searched for homology with the existing DNA and protein sequences stored in GenBank by using BLAST (26 (Fig. 1) . The remaining mice did not develop tumors after prolonged observation, although all the injected cells had an integrated vector. The histology of the tumors was consistent with a poorly differentiated carcinoma and was the same as that of tumors originating from SCC cells converted after MMS treatment (9) (Fig. 2) characteristics between SCC and its various derivative cells is presented in Table 1 .
Integration of the Vector Sequence Tag in the Genomic DNA of Transfection-Converted Tumor Cells. The cloning vector sequence was detected by Southern analysis using vector DNA as a probe (Fig. 3) . With EcoRI digestion, two major DNA fragments (5.5 and 1.8 kb) were detected in cell line SCC-83-01-82CATR1 (Fig. 3, lane 1) . Various DNA fragments were also detected in other transfection-converted CATR tumor cells (Fig. 3, lanes 2-4) . In contrast with the above observed fragment size patterns, the unintegrated library cDNA clones with the same digestion generated cDNA inserts and vector fragments of 4.2, 0.85, and 0.14 kb. These fragment size discrepancies between the expected and observed supported the idea that recombination events of the vector region occurred in vivo. Considering the fact that the cloning vector, pRC/RSV, cannot replicate episomally in human epithelialderived SCC cells, we conclude that the detection and recombination of the vector sequences after extensive cell proliferation have occurred, evidence that the vector was integrated into the genomic DNA.
Expression from the Integrated Library DNA. The expression of the vector-related sequences was examined by Northern analysis of the poly(A)+ RNA isolated from CATR1. A 1.5-kb message was detected by using the cloning vector as a probe after 24-hr exposure (Fig. 4) . Although the cells were selected for neomycin resistance before tumorigenic selection in nude mice, this message was not from the neomycin-resistant gene region of the vector, because it was not detected when this region was used as a probe in the same experiment. However, Table 1 ) and the derivative cell lines are also similar in morphology (data not shown) and tumorigenicity (compare SCC-83-01-82CATR1 with CA in Table 1 ).
The presence of a vector sequence tag in the derivative CATR cells indicated that the integration of the cloning vector used in the construction of the expression library had occurred. The cloning vector cannot maintain itself episomally after such extensive population doubling because the SCC cells do not support its replication.
In the transfection experiments using the same cloning vector, 15 of the 18 ( Table 1 ) in the three positive mice. Therefore, the tumorigenicity must be caused either by the specific cDNA insert expression or by insertional activation or inactivation of a particular endogenous gene. The first possibility is consistent with both Northern analysis and RT-PCR results. CATR1.3 was detected by using whole vector (including the neo region) as a probe after a relatively short exposure (overnight). The filter was then stripped and rehybridized with neo regionspecific probe generated by PCR. This and expressed cDNA insert CATRI.3 indicate the feasibility of this method. These data further raise the possibility that yet unknown genes play a role in the conversion from the nontumorigenic stage to the tumorigenic stage. It appears as though the CATRI.3 cDNA was the most highly expressed gene in CATR1 cells transformed from SCC cells after the transfection of the CA cDNA library. We recovered the CATR1.3 DNA from the tumorigenic clones that retained the tumorigenic phenotype after long-term culture. This isolated DNA can be subcloned into an expression DNA vector(s) and the plasmid characterized to ensure that the protein produced is in the proper reading frame to reintroduce it into SCC cells.
However, RT-PCR results indicate that there may exist several other cDNAs expressed at low levels in the other two CATR cell lines. A variety of chemicals, including MMS and 1-methyl-3-nitro-1-nitrosoguanidine, can cause the tumorigenic conversion of SCC cells with different efficiencies. This indicates the possible existence of parallel/multi-pathways that lead to tumor formation in the SCC background. Our theory is that the specific background of SCC cells (with several gene alterations) requires additional alterations in the mRNA (mutation or expression level change) of one or more of several other genes to exhibit the tumorigenic phenotype. However, we are aware that the inability of the SCC cells and other human tumor cells to form tumors in nude mice may merely be due to small changes in gene function that occur in an unstable genetic population of cells. These small alterations could presumably lead to cell lines from human tumors that can no longer form tumors in nude mice after transplantation.
Large pertubations induced by treatment of nontumorigenic cells with MMS or methylnitronitrosoguanidine are not sufficient to cause a permanent change in the cells as would be expected if small alterations in gene function were enough to restore the tumorigenic phenotype. In fact, the changes induced by MMS are operative only if the treated cells are placed into the nude mouse shortly after treatment.
Next, one would not expect the cells from nontumorigenic human tumors to exhibit consistent behavior since they represent plastic, unstable genetic populations. In fact, all of the nontumorigenic cells that are converted by MMS or by transfection behave remarkably similarly in their inability to form tumors before conversion, latent periods to tumor after treatment, tumor morphology, cultural characteristics in vitro, tumor induction frequencies, and chromosomal properties.
These similar parameters between different human tumors are more representative of phenotypes of cells that had reached a particular stage in neoplastic progression and which require further genetic alteration to express a fully tumorigenic phenotype.
